Actively Recruiting
Randomized Trial Comparing Liquid Phase Concentrated Growth Factor Injection and Conventional Arthrocentesis for Temporomandibular Disc Displacement Management
Led by Horus University · Updated on 2026-08-17
32
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness of Liquid Phase Concentrated Growth Factor LPCGF compared to conventional arthrocentesis in treating internal disc displacement in patients with temporomandibular disorders TMD. This randomized clinical trial aims to provide clear evidence on the safety and potential role of LPCGF as an alternative treatment option for TMD patients with anterior disc displacement. The study includes two groups one group of 16 patients will receive injections of LPCGF, while another group of 16 patients will undergo conventional arthrocentesis. Both treatments are studied for their impact on symptoms related to disc displacement, including pain and jaw movement limitations. Treatment effects will be observed over multiple time points after intervention. Participants will be assessed before treatment and then followed up at 1 week, 1 month, 3 months, and 6 months. Evaluations will include pain levels, mouth opening measurements, joint sounds, jaw movement deviations, and tenderness during jaw palpation. The researchers will monitor these outcomes to compare the two treatments effects and safety over time.
CONDITIONS
Brief Title
Liquid Phase Concentrated Growth Factor Versus Conventional Arthrocentesis in Temporomandibular Disc Displacement
Research Team
M
Mohamed Ali Habib, Teaching assistant
E
Eman AbdElsalam Yousef, Associate professor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here